Skip to main content
Year archive

4SC AG — 2014 filings

All 43 regulatory filings released by 4SC AG (VSC) in 2014, sourced directly from the official regulator.

43 Filings
2014 Period
2014 filings (43)
Filing Released Lang
Press Release: 4SC reports positive topline data from clinical Phase I trial with 4SC-205 in cancer patients using novel continuous dosing scheme
Regulatory Filings
2014-12-09 English
Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2014-11-28 English
Q3 Report 2014
Interim / Quarterly Report 9M 2014
2014-11-07 English
Press Release: 4SC announces financial results for the first nine months and the third quarter of 2014
Earnings Release 9M 2014
2014-11-06 English
Announcement: 4SC to host conference call on 6 November 2014 to present third quarter results of 2014
Report Publication Announcement
2014-10-30 English
Press Release: 4SC further strengthens patent protection for its lead compound resminostat
Regulatory Filings
2014-10-21 English
Press Release: 4SC's partner Yakult Honsha completes Phase I part of clinical study with resminostat in Asian NSCLC patients and starts randomised Phase II part
Earnings Release Q3 2014
2014-10-07 English
Press Release: 4SC's partner Yakult Honsha completes Phase I part of clinical study with resminostat in Asian HCC patients and starts randomised Phase II part
Legal Proceedings Report
2014-09-23 English
4SC AG issues second tranche of convertible notes with a nominal amount of EUR 500,000 to Yorkville
Capital/Financing Update
2014-09-03 English
4SC AG: Dr Thomas Werner and Klaus Kuhn announce resignation from Supervisory Board
Board/Management Information
2014-08-18 English
Q2 Report 2014
Interim / Quarterly Report H1 2014
2014-08-08 English
Press Release: 4SC Announces Financial Results for the First Half of 2014
Earnings Release H1 2014
2014-08-07 English
Announcement: 4SC to host conference call on 7 August 2014 to present second quarter results of 2014
Regulatory Filings
2014-07-31 English
Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2014-07-31 English
Press Release 4SC: CRELUX and 4SC Discovery awarded research grant for new epigenetic cancer drugs
Regulatory Filings
2014-07-24 English
Presse Release: 4SC hires experienced pharmaceutical manager and oncology expert
Board/Management Information
2014-07-03 English
Press Release 4SC: Reallocation of 4SC shares successfully completed, free float increased
Major Shareholding Notification
2014-07-02 English
Declaration of Voting Results & Voting Rights Announcements 2014
Declaration of Voting Results & Voting Rights Announcements
2014-07-02 English
4 SC AG: Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2014-06-30 English
4SC secures financing with shareholder loan of up to EUR 10 million
Capital/Financing Update
2014-06-05 English
4 SC AG: Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2014-05-30 English
4SC announces positive top line data from clinical Phase I trial with epigenetic cancer drug 4SC-202 in patients with haematological tumours at ASCO
Regulatory Filings
2014-05-28 English
Declaration of Voting Results & Voting Rights Announcements 2014
Declaration of Voting Results & Voting Rights Announcements
2014-05-23 English
Declaration of Voting Results & Voting Rights Announcements 2014
Declaration of Voting Results & Voting Rights Announcements
2014-05-23 English
Veroffentlichung gema 30e WpHG mit dem Ziel der europaweiten Verbreitung
Share Issue/Capital Change
2014-05-20 German
Datum:13.05.2014
Annual Report FY 2013
2014-05-13 German
DGAP-DD: 4SC AG english
Director's Dealing
2014-05-12 English
Q1 Report 2014
Interim / Quarterly Report Q1 2014
2014-05-10 English
Press Release: 4SC Announces Financial Results for the First Quarter of 2014
Earnings Release Q1 2014
2014-05-08 English
Press Release: 4SC's partner Yakult Honsha completes Phase I study with resminostat in Japanese patients with solid tumors, 4SC eligible for milestone payment
Regulatory Filings
2014-05-06 English
Announcement: 4SC to host conference call on 8 May 2014 to present first quarter results of 2014
Report Publication Announcement
2014-05-02 English
4 SC AG: Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements
2014-04-30 English
Declaration of Voting Results & Voting Rights Announcements 2014
Declaration of Voting Results & Voting Rights Announcements
2014-04-15 English
Press Release: 4SC Discovery receives EU grant worth EUR 450,000 for the research of new epigenetic compounds against stroke
Regulatory Filings
2014-04-15 English
Annual Financial Statements 2013
Annual Report FY 2013
2014-04-07 English
Jahresfinanzbericht 2013
Annual Report FY 2013
2014-04-07 German
4 SC AG: Bekanntmachung der Einberufung zur Hauptversammlung am 09.05.2014 in Munchen mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2014-03-31 German
4 SC AG: Veroffentlichung der Gesamtzahl der Stimmrechte nach 26a WpHG mit dem Ziel der europaweiten Verbreitung
Declaration of Voting Results & Voting Rights Announcements
2014-03-31 German
Press Release: 4SC publishes results for financial year 2013 and announces changes to the Management Board
Earnings Release FY 2013
2014-03-26 English
Press Release: 4SC Discovery collaborates with Heidelberg University Hospital and receives EUR 1.3 million for research and preclinical development of new malaria drug
Regulatory Filings
2014-03-20 English
Announcement: 4SC to host conference call on 26 March 2014 to present annual results 2013
Report Publication Announcement
2014-03-19 English
4SC AG issues first tranche of convertible notes with a nominal amount of EUR 500,000 to Yorkville
Capital/Financing Update
2014-03-04 English
Continued funding of 4SC AG - Investor undertakes to subscribe to convertible notes for up to EUR 15 million nominally
Capital/Financing Update
2014-02-12 English